Stock Market & Financial News
Contact Levi & Korsinsky by June 10, 2025 Deadline to Join Class Action Against BigBear.ai Holdings, Inc. (BBAI)
NEW YORK, NY / ACCESS Newswire / April 28, 2025 / If you suffered a loss on your BigBear.ai Holdings, Inc. (NYSE:BBAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
May 27, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ATNM
NEW YORK, NY / ACCESS Newswire / April 28, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
iHuman Inc. Files 2024 Annual Report on Form 20-F
BEIJING , April 28, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it filed its annual report on Form 20-F for the year ended December 31, 2024 with the U.S. Securities and Exchange Commission on April 28, 2025. The annual report on Form 20-F is available on the Company's investor relations website at Click Here
Steelcase: Backlog Strength, Office Recovery, Diversification Efforts, And Low Valuation
Steelcase Inc. has strong growth potential driven by improving order trends, a robust backlog, and diversification into healthcare, education, and SMB markets. Despite near-term margin headwinds from tariffs and ERP system implementation, cost reduction initiatives and pricing increases should support future margin expansion. The stock trades at a significant discount to its historical average, offering a compelling buy opportunity given its growth prospects and healthy dividend yield.
IBM takes a cue from Apple with $150 billion investment — but here's the twist
IBM doesn't do much overseas manufacturing but may be trying to protect some of its consulting contracts with the U.S. government.
Sokoman Minerals Updates Shareholders on Vinland Shares Spin-Out
St. John's, Newfoundland--(Newsfile Corp. - April 28, 2025) - Sokoman Minerals Corp. (TSXV: SIC) (OTCQB: SICNF) ("Sokoman" or the "Company") further to its April 25, 2025 news release, the Company announces that its planned spin-out of approximately half of its shares of Vinland Lithium Inc. ("Vinland") has been completed. Accounts holding at least 8,000 Sokoman shares will see approximately 50 Vinland shares credited for each 8,000 Sokoman shares owned with the credit effective May 7, 2025.
Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion
WARREN, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), reaffirms its top-line revenue forecast for its oncology pipeline, projecting $1 billion in revenue in its launch year and a cumulative 5-year estimate of between $10 billion and $14 billion. The forecast reflects the company's unique, faster, and cost-efficient drug development model which has the potential to serve as a blueprint to ensure sustainable medical innovation for years to come.
Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting
Prolonged duration of response, deep B-cell depletion, and well-tolerated safety profile support the potential of AlloNK® + rituximab for the treatment of B-cell driven diseases in a community setting
Manhattan Associates, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. April 28, 2025 Deadline to file Lead Plaintiff Motion.
Investors can contact the law firm at no cost to learn more about recovering their losses
Mysterious financier asks judge to stop Canoo asset sale
A mysterious investor out of London has asked a bankruptcy judge in Delaware to stop the sale of EV startup Canoo's assets to its CEO, calling it a “flawed” process.
BLZE Announcement: If You Have Suffered Losses in Backblaze, Inc. (NASDAQ: BLZE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Backblaze, Inc. (NASDAQ: BLZE) resulting from allegations that Backblaze may have issued materially misleading business information to the investing public.
SEB SA (SEBYF) Q1 2025 Earnings Call Transcript
SEB SA (OTCPK:SEBYF) Q1 2025 Earnings Conference Call April 24, 2025 12:00 PM ET Company Participants Stanislas de Gramont - Chief Executive Officer Olivier Casanova - Chief Financial Officer Conference Call Participants Louise Wiseur - UBS Geoffrey d'Halluin - BNP Paribas Christophe Chaput – ODDO Alessandro Cecchini - Equita Operator Hello, and welcome to SEB 2025 First Quarter Sales and Financial Data hosted by Stanislas de Gramont, Chief Executive Officer; and Olivier Casanova, Chief Financial Officer. My name is Melissa, and I will be your coordinator for today's event.
Editas Medicine to Present Preclinical Data Demonstrating Progress in the Development of an in vivo Gene Editing Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that five abstracts have been accepted for presentation, including one oral presentation, at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) being held May 13 – 17, 2025, in New Orleans, LA, and virtually. The Company is presenting preclinical data to support its development of transformative in vivo gene editing medicines.
Blade Air Mobility Announces Date for First Quarter Ending March 31, 2025 Earnings Release Conference Call
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade” or the “Company”), will release financial results for the first quarter ended March 31, 2025 on Monday, May 12, 2025 before the market opens. The company will hold a conference call the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Rob Wiesenthal, Blade's Chief Executive Officer, and Will Heyburn, Blade's Chief Financial Officer, and will include a question-and-answer session for call participants.
LINKBANCORP, Inc. Announces Record First Quarter 2025 Earnings and Declares Dividend
HARRISBURG, Pa. , April 28, 2025 /PRNewswire/ -- LINKBANCORP, Inc. (NASDAQ: LNKB) (the "Company"), the parent company of LINKBANK (the "Bank"), reported record net income of $15.3 million, or $0.41 per diluted share, for the quarter ended March 31, 2025, compared to net income of $7.6 million, or $0.20 per diluted share, for the quarter ended December 31, 2024.
Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today unveils research data on TALEN®-mediated non-viral transgene insertion for advancing cellular and gene therapies, and advancements in genetic editing using TALE base editors (TALEB), at the Society of Gene and Cell Therapy (ASGCT) annual meeting, that will be held on May 13-17, 2025 in New Orleans.
REMAX Names Daniel Dennis SVP of Sales and Service, Reinforcing Commitment to Broker and Agent Success
Dennis joins REMAX from Illustrated Properties in South Florida with two decades of experience in brokerage operations. DENVER , April 28, 2025 /PRNewswire/ -- In a continued effort to elevate broker and agent success across the network, REMAX®, the #1 name in real estate*, is proud to announce Daniel Dennis has joined the brand as Senior Vice President of Sales and Service.
Fractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting
BURLINGTON, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (“the Company”), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes of obesity and type 2 diabetes (T2D), today announced that it will deliver an oral presentation of compelling preclinical data from its Rejuva single-administration Smart GLP-1 pancreatic gene therapy platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting, taking place May 13-17, 2025, in New Orleans, Louisiana.
Rocket Lab USA, Inc. Class Action: Levi & Korsinsky Reminds Rocket Lab Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 28, 2025 – RKLB
NEW YORK, NY / ACCESS Newswire / April 28, 2025 / If you suffered a loss on your Rocket Lab USA, Inc. (NASDAQ:RKLB) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Nordson Corporation Announces Medical and Fluid Solutions Segment Leadership Transition
WESTLAKE, Ohio--(BUSINESS WIRE)--Justin Hall promoted to Executive Vice President (EVP) and Medical and Fluid Solutions (MFS) segment leader.
EarthLabs Reports Results For The Fourth Quarter and Fiscal Year 2024
Ended the year with total cash, cash equivalents, and investments of $39,234,437; 172.1% increase in advertising revenue as compared to Q4 2024 with advertising revenue of $6,108,765 for the year ended December 31, 2024 (176.9% increase); 39.9% increase in subscriptions revenue as compared to Q4 2024 with subscription revenue of $1,237,035 for the year ended December 31, 2024 (41.3% increase); Toronto, Ontario--(Newsfile Corp. - April 28, 2025) - EarthLabs Inc. (TSXV: SPOT) (OTCQX: SPOFF) (FSE: 8EK0) ("EarthLabs" or the "Company") is pleased to announce the consolidated financial results for three months and year ended December 31, 2024 of the Company (the "Financial Results"). Highlights for the three-months period ended December 31, 2024: 172.1% increase in Advertising revenue to $1,843,012 as compared to $677,279 for the three months ended December 31, 2023; 39.9% increase in Subscriptions revenue to $322,338 as compared to $230,391 for the three months ended December 31, 2023; 12.0% increase in Sales of exploration maps to $37,655 as compared to $33,610 for the three months ended December 31, 2023; Net investment losses of $3,667,473 from our investment portfolio as compared to $1,263,270 for the three months ended December 31, 2023; Net loss and comprehensive loss of $4,959,177(basic loss per share of $0.04) as compared to net loss and comprehensive loss of $11,220,627 (basic loss per share of $0.08) for the three months ended December 31, 2023.
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that the company will participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference scheduled for May 5-6 2025 in Toronto, Ontario.
Terra Clean Energy Corp. Plans Summer Drill Program at South Falcon East
Vancouver B.C. - TheNewswire - April 28, 2025 – TERRA CLEAN ENERGY CORP. (“ Terra ” or the “ Company ”) (CSE: TCEC, OTCQB: TCEFF , FSE: 9O0 , is pleased to announce an upcoming summer drill program at the South Falcon East Uranium Project (the “ Property ”) which hosts the Fraser Lakes B Uranium Deposit. The Property lies 18 km outside the edge of the Athabasca Basin, approximately 50 km east of the Key Lake uranium mill and former mine (Figure 1). The Company entered into an option agreement with Skyharbour Resources Ltd. (“ Skyharbour ”) in October of 2022 whereby the company can earn up to a 75% interest in the Property.
Shareholders that lost money on Canopy Growth Corporation(CGC) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESS Newswire / April 28, 2025 / If you suffered a loss on your Canopy Growth Corporation (NASDAQ:CGC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting
Preclinical data to showcase the potential of regRNA-targeting to increase protein levels in a clinically meaningful way by upregulating gene expression
Heritage Distilling Co. Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance
GIG HARBOR, Wash., April 28, 2025 (GLOBE NEWSWIRE) -- Heritage Distilling Holding Company, Inc. (“HDC” or “Heritage” or the “Company”) (Nasdaq: CASK), a leading craft distiller of innovative premium brands, today reported it regained compliance with the Nasdaq regarding the filing of periodic reports after filing its 2024 Annual Report of Form 10-K with the Securities and Exchange Commission on April 28, 2025.
TFI International Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 13, 2025 to Discuss Your Rights – TFII
NEW YORK, NY / ACCESS Newswire / April 28, 2025 / If you suffered a loss on your TFI International Inc. (NYSE:TFII) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
PHILADELPHIA, April 28, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century', NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today announced two presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting, which is being held from May 13-17, 2025, at the New Orleans Ernest N. Morial Convention Center in New Orleans, LA. The presentations will highlight data supporting the company's emerging preclinical cell therapy pipeline and investigational programs for autoimmune diseases and cancer.
Nucor Reports Results for the First Quarter of 2025
First Quarter of 2025 Highlights Net earnings attributable to Nucor stockholders of $156 million, or $0.67 per diluted share. Adjusted net earnings attributable to Nucor stockholders of $179 million, or $0.77 per diluted share.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 27, 2025 in Solaris Energy Infrastructure, Inc. Lawsuit – SEI
NEW YORK, NY / ACCESS Newswire / April 28, 2025 / If you suffered a loss on your Solaris Energy Infrastructure, Inc. (NYSE:SEI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
